Orthopedic Devices Patents: Top Companies & Filing Trends 2026
- Filing has cooled since its 2017 peak of 208 records. the 2021-to-2024 span alone fell 57%, from 202 to 87, though the two most recent years are still filling in under an 18-month publication lag.
- No single company dominates. the leader holds 283 records out of 5,142, and the top 5 combined account for just 17.8% of all records in scope — this is a fragmented field, not a walled one.
- Surgical and implant classes carry the bulk of the art. A61B (diagnosis & surgery) and A61F (implants & prostheses) touch 53.1% and 40.5% of records respectively, while electrotherapy and peptide-related classes sit under 4%.
Filing growth compares 2021 (202 records) with 2024 (87) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 5,142 records in scope (CR5), not by the ranked leaders only.
What the orthopedic device patent record actually shows
The dataset covers 5,142 published records filed against orthopedic device claims spanning device geometry, implant materials, fixation elements and surgical procedure methods, filed between 2015 and mid-2026. Filing activity peaked in 2017 at 208 records and has since declined, though the most recent one to two years are understated because publication typically lags filing by roughly 18 months. The assignee base is a ranked field of 100 companies rather than a small oligopoly: the leader holds 283 records, but combined the top 5 account for only 17.8% of all records in scope.
Most of the technical weight sits in surgical and implant-focused IPC subclasses, with diagnosis-and-surgery (A61B) and implants-and-prostheses (A61F) each touching a large share of records. Sterilising and disinfecting methods (A61L) and medicinal-preparation classes (A61K) carry meaningful but secondary volume, while electrotherapy, therapeutic-compound activity and peptide-related classes remain comparatively thin — a signal of where claim density has not yet built up.
Filing trends and technology composition
Two views of the same 5,142-record dataset: how volume has moved year over year, and how records distribute across IPC subclasses. Both use the full record count as the denominator.
Filing peaked in 2017 and has since pulled back
Annual filings ran at 208 in 2017, the high point of the series. The 2021-to-2024 window, the last span with reasonably complete publication data, shows a 57% drop from 202 to 87 records. Years after 2024 are present in the data but should be read as provisional, since publication lag means recent filings have not all surfaced yet.
Surgical and implant classes dominate the composition
A61B (diagnosis & surgery) appears on 53.1% of the 5,142 records and A61F (implants & prostheses) on 40.5%, making these two subclasses the structural core of the field. A61L (sterilising & disinfecting) and A61K (medicinal preparations) follow at 25.3% and 19.2%. Because records can carry multiple IPC codes, these shares sum to well over 100% — that is expected and reflects how often surgical and implant claims are filed together.
Shares are the percentage of the 5,142 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Orthopedic Devices Patent Landscape with Eureka
This page is one run against one query. Ask Eureka your own question about orthopedic devices patent landscape and every answer comes back with the patent numbers behind it.
Try EurekaThe most-cited records anchoring this field
Computer-based training methods for surgical procedures
A method is disclosed for analyzing surgical techniques using a computer system for gathering and analyzing surgical data acquired during a surgical procedure on a body portion and comparing that data to pre-selected target values for the particular surgical procedure. The inventive method allows the surgeon to measure the technical success of a surgical procedure in terms of quantifiable geometric, spatial, kinematic or kinetic parameters, calculated from data collected during the procedure and compared against surgeon-defined or conventional target values.Filed by NOBLE, PHILIP C., published as US20040030245A1.
| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US5553675A | Orthopedic surgical device | 2,302 |
| 2 | US20040167572A1 | Coated medical devices | 1,969 |
| 3 | US6838493B2 | Medical devices and applications of polyhydroxyalkanoate polymers | 1,833 |
| 4 | US7108701B2 | Drug releasing anastomosis devices and methods for treating anastomotic sites | 1,779 |
| 5 | US5171253A | Velcro-like closure system with absorbable suture materials for absorbable hemostatic clips and surgical stri… | 1,723 |
| 6 | US5732821A | System for sterilizing medical devices | 1,573 |
| 7 | US8273404B2 | Extraction of solvents from drug containing polymer reservoirs | 1,352 |
| 8 | US6852122B2 | Coated endovascular AAA device | 1,339 |
| 9 | US8790684B2 | Vascular closure device | 1,309 |
| 10 | US5792573A | Rechargeable battery adapted to be attached to orthopedic device | 1,244 |
Citation counts favour older records simply because they have had more time to accumulate citations inside the corpus — treat them as a marker of influence on later filings, not as a measure of current commercial relevance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the data means for filing decisions
Three read-throughs from the volume, concentration and citation data above.
The field is fragmented, not gated
With the leader at 283 records and the top 5 combined holding only 17.8% of all 5,142 records in scope, no single filer controls the surgical or implant claim space. A long tail of moderate filers and single-filing entrants makes up the rest, which means freedom-to-operate analysis has to look well beyond the largest names.
Volume has pulled back from its 2017 high
Filings fell from 202 in 2021 to 87 in 2024, a 57% drop over that span. This follows a broader decline from the 2017 peak of 208 and should be read as a real slowdown in the complete years, not as a signal about 2025 or 2026, which are still filling in under publication lag.
Surgical method claims carry the most weight
A61B (diagnosis & surgery) touches over half of all records, ahead of A61F (implants & prostheses) at 40.5%. Electrotherapy (A61N) and peptide-related classes (C07K) sit under 4% and 3% respectively, marking them as comparatively open relative to the surgical core.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to orthopedic devices patent landscape, with the prior art for and against each one.
Who holds the strongest positions, and where activity has stalled
The ranked assignee list spans 100 companies, from a leader with 283 records down through a long tail. Recent-year momentum data shows several established filers with little or no activity in the latest year, which is as informative as the raw counts.
One filer sits well ahead, but not dominantly
The top-ranked assignee holds 283 records against a field of 5,142 — a strong single position, but nowhere near a majority. Fifth place already drops to 121 records and tenth place to 80, showing a steep but shallow curve rather than a plateau.
A handful of tight co-assignee clusters exist
The data surfaces 10 co-assignee pairs, with the strongest pairings linking related corporate entities under the same parent group. This pattern points to internal group filing structure more than open collaboration between unrelated companies.
Multiple historic filers show no recent activity
Several assignees that built up meaningful historical portfolios show zero filings in the latest year, including entities with prior double-digit annual output. That does not necessarily mean exit from the field — it may reflect publication lag — but it is a clear signal to check recent M&A or portfolio consolidation before assuming continued activity.
| Assignee | Recent year | YoY |
|---|---|---|
| Canary Medical Inc. | 1 | -67% |
| Cordis Corporation | 0 | — |
| Warsaw Orthopedic, Inc. | 0 | — |
| Smith & Nephew, Inc. | 0 | -100% |
| Biomet Manufacturing, LLC | 0 | — |
| ANGIOTECH INT AG (CH) | 0 | — |
| DePuy Synthes Products, Inc. | 0 | -100% |
| Michelle Technologies | 0 | — |
Where to take this analysis
The dataset points to a field with a fragmented top, a cooling filing rate, and a small number of technically thin sub-areas. The next steps depend on whether the goal is freedom-to-operate, portfolio strategy, or identifying a filing gap.
Map claim boundaries around the surgical core
A61B and A61F together carry the bulk of filing activity, so any new surgical-method or implant-geometry claim needs a careful prior-art check against this dense core before drafting.
Explore claims in EurekaCheck the under-claimed branches
Electrotherapy, peptide-related and physiological-signal classes sit under 4% of records each, suggesting more room to stake out a first-mover claim than in the surgical core.
Run a white-space search in EurekaVerify recent-year filer status before relying on rankings
Several ranked assignees show zero latest-year activity, which could reflect publication lag or a real exit — confirm current filing behaviour before treating the ranking as a live competitive map.
Track assignee activity in EurekaCommon questions on orthopedic device patents
The ranked assignee list covers 100 companies, with the leader holding 283 records out of 5,142 in scope. The top 5 combined account for 17.8% of all records, which means the field is led but not dominated by any single company. Beyond the top ranks, filing activity spreads across a long tail of moderate and single-filing entrants, so a full competitive picture requires looking past just the largest names.
Filing peaked in 2017 at 208 records and has declined since, with the 2021-to-2024 span showing a 57% drop from 202 to 87 records. That three-year window is the most reliable recent trend because publication typically lags filing by around 18 months, making 2025 and 2026 figures incomplete. Based on the complete years, the trend is a real pullback from the 2017 high rather than a plateau.
Diagnosis-and-surgery methods (IPC class A61B) appear on 53.1% of the 5,142 records, and implants-and-prostheses (A61F) on 40.5%, making these the two densest areas. Sterilising-and-disinfecting methods (A61L) and medicinal preparations (A61K) follow at 25.3% and 19.2%. Electrotherapy, therapeutic-compound activity and peptide-related classes each sit under 8%, indicating comparatively lighter claim density there.
The IPC composition data points to electrotherapy (A61N, 3.4% of records) and peptide-related chemistry (C07K, 2.7%) as the thinnest classes relative to the surgical and implant core. Sub-areas like electrotherapy-integrated fixation elements or physiological-signal feedback for implant monitoring sit at the intersection of these under-claimed classes and the busier implant space. Confirming this with a targeted prior-art search is still necessary before assuming any specific claim is open.
US20040030245A1 describes a computer-based method for analyzing surgical technique by comparing data gathered during a procedure against pre-selected target values for geometric, spatial, kinematic or kinetic parameters. It sits in the surgical-training and outcome-measurement space rather than in implant geometry or fixation-element design. Anyone filing around computer-assisted surgical performance measurement should review its claims closely, but it does not appear to reach into implant material or physiological-interface claims based on its abstract.
Research Orthopedic Devices Patent Landscape in depth with Eureka
Go past this page: query the whole orthopedic devices patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.